Study of Celecoxib Bioavailability in Healthy Subjects

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.24 enrolled

Overview

To evaluate the bioavailability of celecoxib administered as capsule contents sprinkled onto applesauce relative to intact capsule

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Sex: ALLMin age: 18 YearsMax age: 55 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Healthy male and/or female subjects Exclusion Criteria: * Standard criteria for healthy volunteer studies

Pfizer Investigational Site

New Haven, Connecticut, United States

Relative bioavailability of celecoxib administered as capsule contents sprinkled onto applesauce relative intact capsule after a single dose

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.